Chemed Corp. (CHE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1152101,
    "name": "Chemed Corp.",
    "stock_name": "Chemed Corp.",
    "full_name": "Chemed Corp.",
    "name_url": "stocks-analysis/chemed-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "424.30",
    "chg": -6.53,
    "chgp": "-1.52%",
    "dir": -1,
    "prev_price": "430.83",
    "mcapval": "16,531.72",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 3360,
    "indexname": "S&P 500",
    "isin": "US16359R1032",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "252.96 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/chemed-corp-1152101-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Chemed Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/chemed-corps-technical-trend-changes-from-mildly-bearish-to-bearish-amid-ongoing-challenges-3651992",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ChemedCorp_technicaldot_3651992.png",
        "date": "2025-10-28 15:11:03",
        "description": "Chemed Corp., a small-cap hospital industry player, has experienced stock fluctuations, with a current price of $436.78. The company has faced challenges, underperforming the S&P 500 over the past year and year-to-date. Technical indicators present mixed signals, suggesting a cautious outlook for the stock."
      },
      {
        "title": "Is Chemed Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-chemed-corp-technically-bullish-or-bearish-3651262",
        "imagepath": "",
        "date": "2025-10-28 11:38:57",
        "description": "As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages and both weekly and monthly Bollinger Bands. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating mixed signals across time frames. The KST is mildly bullish weekly but bearish monthly, while the Dow Theory presents a mildly bearish weekly and mildly bullish monthly stance. \n\nIn terms of performance, Chemed Corp. has underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -17.59% compared to the S&P 500's 15.47%, and a one-year return of -26.85% versus 16.90% for the index...."
      },
      {
        "title": "Is Chemed Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-chemed-corp-technically-bullish-or-bearish-3647714",
        "imagepath": "",
        "date": "2025-10-27 11:50:08",
        "description": "As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, driven by bearish signals across multiple indicators. The MACD is bearish on a monthly basis, while Bollinger Bands and moving averages are also indicating bearish trends. The KST shows a mildly bullish weekly signal, but overall, the weekly Dow Theory and OBV are both mildly bearish. \n\nIn terms of performance, Chemed Corp. has underperformed significantly compared to the S&P 500 across all multi-period returns, with a year-to-date return of -17.59% versus the S&P 500's 15.47%, and a one-year return of -26.85% compared to the S&P 500's 16.90%...."
      },
      {
        "title": "Is Chemed Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-chemed-corp-technically-bullish-or-bearish-3646249",
        "imagepath": "",
        "date": "2025-10-26 11:24:51",
        "description": "As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, driven by bearish signals in the daily moving averages and Bollinger Bands, alongside a bearish monthly MACD. The weekly indicators show mixed signals, with the MACD and KST being mildly bullish, but the overall trend remains negative. \n\nIn terms of performance, Chemed Corp. has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -17.59% compared to the S&P's 15.47%, and a one-year return of -26.85% versus 16.90%...."
      },
      {
        "title": "Is Chemed Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-chemed-corp-overvalued-or-undervalued-3637425",
        "imagepath": "",
        "date": "2025-10-21 12:01:58",
        "description": "As of 17 October 2025, the valuation grade for Chemed Corp. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 65, a Price to Book Value of 16.99, and an EV to EBITDA ratio of 44.10, all of which are significantly higher than industry averages. In comparison, Universal Health Services, Inc. has a P/E ratio of 9.20 and an EV to EBITDA of 6.78, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51 and an EV to EBITDA of 9.12.\n\nRecent performance shows that Chemed Corp. has underperformed against the S&P 500, with a year-to-date return of -16.84% compared to the S&P 500's 13.30%. This further reinforces the notion that the stock is overvalued given its high valuation ratios and poor relative performance...."
      },
      {
        "title": "Chemed Corp. Experiences Revision in Stock Evaluation Amidst Competitive Hospital Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/chemed-corp-sees-valuation-grade-shift-from-fair-to-very-expensive-3640577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ChemedCorp_valuationdot_3640577.png",
        "date": "2025-10-20 15:46:07",
        "description": "Chemed Corp., a small-cap hospital industry player, has adjusted its valuation metrics, showing a high P/E ratio of 65 and a price-to-book value of 16.99. The company demonstrates strong profitability with a ROCE of 37.01% and ROE of 26.14%, though its low dividend yield of 0.15% may affect investor perception."
      },
      {
        "title": "Is Chemed Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-chemed-corp-overvalued-or-undervalued-3634291",
        "imagepath": "",
        "date": "2025-10-20 12:19:47",
        "description": "As of 17 October 2025, the valuation grade for Chemed Corp. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 65, significantly higher than its peers, such as Universal Health Services, Inc. with a P/E of 9.21 and National HealthCare Corp. at 18.51. Additionally, Chemed's EV to EBITDA ratio stands at 44.10, which is also elevated compared to the industry average.\n\nWith a PEG ratio of 6.80, Chemed Corp. appears to be priced excessively relative to its growth prospects. The company's return metrics further reinforce this valuation concern, as it has underperformed the S&P 500 with a year-to-date return of -16.84% compared to the index's 13.30%. Overall, these indicators suggest that Chemed Corp. is overvalued in the current market environment...."
      },
      {
        "title": "Is Chemed Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-chemed-corp-overvalued-or-undervalued-3631831",
        "imagepath": "",
        "date": "2025-10-19 11:57:25",
        "description": "As of 17 October 2025, the valuation grade for Chemed Corp. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 65, a Price to Book Value of 16.99, and an EV to EBITDA of 44.10, all of which suggest a premium valuation compared to its peers. Notably, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, highlighting the stark contrast in valuation metrics within the industry.\n\nChemed Corp.'s recent performance shows a significant decline, with a year-to-date return of -16.84% compared to the S&P 500's gain of 13.30%, and a 1-year return of -28.08% against the index's 14.08% increase. These figures reinforce the notion that Chemed Corp. is overvalued in the current market environment...."
      },
      {
        "title": "Is Chemed Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-chemed-corp-technically-bullish-or-bearish-3544728",
        "imagepath": "",
        "date": "2025-09-20 18:54:53",
        "description": "As of 10 September 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including a bearish MACD on the monthly timeframe, a bearish KST, and a bearish Dow Theory on both weekly and monthly periods. The moving averages are also indicating a mildly bearish trend on the daily timeframe. \n\nIn terms of performance, Chemed Corp. has underperformed the S&P 500 across multiple periods, with a year-to-date return of -13.51% compared to the S&P 500's 12.22%, and a one-year return of -20.67% versus the S&P 500's 17.14%...."
      }
    ],
    "total": 15,
    "sid": "1152101",
    "stock_news_url": "https://www.marketsmojo.com/news/chemed-corp-1152101"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Chemed Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-10-28 15:11:03

Chemed Corp., a small-cap hospital industry player, has experienced stock fluctuations, with a current price of $436.78. The company has faced challenges, underperforming the S&P 500 over the past year and year-to-date. Technical indicators present mixed signals, suggesting a cautious outlook for the stock.

Is Chemed Corp. technically bullish or bearish?

2025-10-28 11:38:57

As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages and both weekly and monthly Bollinger Bands. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating mixed signals across time frames. The KST is mildly bullish weekly but bearish monthly, while the Dow Theory presents a mildly bearish weekly and mildly bullish monthly stance. In terms of performance, Chemed Corp. has underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -17.59% compared to the S&P 500's 15.47%, and a one-year return of -26.85% versus 16.90% for the index....

Is Chemed Corp. technically bullish or bearish?

2025-10-27 11:50:08

As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, driven by bearish signals across multiple indicators. The MACD is bearish on a monthly basis, while Bollinger Bands and moving averages are also indicating bearish trends. The KST shows a mildly bullish weekly signal, but overall, the weekly Dow Theory and OBV are both mildly bearish. In terms of performance, Chemed Corp. has underperformed significantly compared to the S&P 500 across all multi-period returns, with a year-to-date return of -17.59% versus the S&P 500's 15.47%, and a one-year return of -26.85% compared to the S&P 500's 16.90%....

Is Chemed Corp. technically bullish or bearish?

2025-10-26 11:24:51

As of 24 October 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, driven by bearish signals in the daily moving averages and Bollinger Bands, alongside a bearish monthly MACD. The weekly indicators show mixed signals, with the MACD and KST being mildly bullish, but the overall trend remains negative. In terms of performance, Chemed Corp. has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -17.59% compared to the S&P's 15.47%, and a one-year return of -26.85% versus 16.90%....

Is Chemed Corp. overvalued or undervalued?

2025-10-21 12:01:58

As of 17 October 2025, the valuation grade for Chemed Corp. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 65, a Price to Book Value of 16.99, and an EV to EBITDA ratio of 44.10, all of which are significantly higher than industry averages. In comparison, Universal Health Services, Inc. has a P/E ratio of 9.20 and an EV to EBITDA of 6.78, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51 and an EV to EBITDA of 9.12. Recent performance shows that Chemed Corp. has underperformed against the S&P 500, with a year-to-date return of -16.84% compared to the S&P 500's 13.30%. This further reinforces the notion that the stock is overvalued given its high valuation ratios and poor relative performance....

Chemed Corp. Experiences Revision in Stock Evaluation Amidst Competitive Hospital Sector Dynamics

2025-10-20 15:46:07

Chemed Corp., a small-cap hospital industry player, has adjusted its valuation metrics, showing a high P/E ratio of 65 and a price-to-book value of 16.99. The company demonstrates strong profitability with a ROCE of 37.01% and ROE of 26.14%, though its low dividend yield of 0.15% may affect investor perception.

Is Chemed Corp. overvalued or undervalued?

2025-10-20 12:19:47

As of 17 October 2025, the valuation grade for Chemed Corp. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 65, significantly higher than its peers, such as Universal Health Services, Inc. with a P/E of 9.21 and National HealthCare Corp. at 18.51. Additionally, Chemed's EV to EBITDA ratio stands at 44.10, which is also elevated compared to the industry average. With a PEG ratio of 6.80, Chemed Corp. appears to be priced excessively relative to its growth prospects. The company's return metrics further reinforce this valuation concern, as it has underperformed the S&P 500 with a year-to-date return of -16.84% compared to the index's 13.30%. Overall, these indicators suggest that Chemed Corp. is overvalued in the current market environment....

Is Chemed Corp. overvalued or undervalued?

2025-10-19 11:57:25

As of 17 October 2025, the valuation grade for Chemed Corp. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 65, a Price to Book Value of 16.99, and an EV to EBITDA of 44.10, all of which suggest a premium valuation compared to its peers. Notably, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, highlighting the stark contrast in valuation metrics within the industry. Chemed Corp.'s recent performance shows a significant decline, with a year-to-date return of -16.84% compared to the S&P 500's gain of 13.30%, and a 1-year return of -28.08% against the index's 14.08% increase. These figures reinforce the notion that Chemed Corp. is overvalued in the current market environment....

Is Chemed Corp. technically bullish or bearish?

2025-09-20 18:54:53

As of 10 September 2025, the technical trend for Chemed Corp. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including a bearish MACD on the monthly timeframe, a bearish KST, and a bearish Dow Theory on both weekly and monthly periods. The moving averages are also indicating a mildly bearish trend on the daily timeframe. In terms of performance, Chemed Corp. has underperformed the S&P 500 across multiple periods, with a year-to-date return of -13.51% compared to the S&P 500's 12.22%, and a one-year return of -20.67% versus the S&P 500's 17.14%....

View All News